A variety of EGFR-targeting molecules have been utilized to effectively and selectively deliver nanocarriers to tumor stroma, including monoclonal antibodies, single-chain antibodies, nanobodies, affimers, affinity peptides, and oligonucleotide aptamers [623,624,625,626,627,628,629,630]. Here, EGFR is linked to neoplasm.